Insider Transactions in Q1 2022 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
23,003
-9.69%
|
$575,075
$25.7 P/Share
|
|
Mar 04
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,407
+4.96%
|
$22,035
$5.98 P/Share
|
|
Mar 03
2022
|
Bonnie H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,667
+16.93%
|
-
|
|
Mar 03
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,412
+34.65%
|
-
|
|
Mar 03
2022
|
Marc Stapley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,537
+35.26%
|
-
|
|
Mar 03
2022
|
Rebecca Chambers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,728
+27.47%
|
-
|
|
Mar 03
2022
|
Tina Susan Nova President, CLIA U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
56,546
+42.35%
|
-
|
|
Mar 02
2022
|
Tina Susan Nova President, CLIA U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
10,695
-34.35%
|
$288,765
$27.84 P/Share
|
|
Mar 02
2022
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,337
-21.58%
|
$279,099
$27.84 P/Share
|
|
Mar 02
2022
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,521
-6.15%
|
$122,067
$27.84 P/Share
|
|
Feb 28
2022
|
Annie Mc Guire SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,855
+50.0%
|
-
|
|
Jan 11
2022
|
Evan/ Fa Jones Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.26%
|
$20,000
$4.0 P/Share
|